Provided by Tiger Trade Technology Pte. Ltd.

Pacira Pharmaceuticals

22.88
-0.4300-1.84%
Post-market: 22.880.00000.00%17:30 EDT
Volume:494.32K
Turnover:11.37M
Market Cap:926.41M
PE:144.96
High:23.37
Open:23.19
Low:22.74
Close:23.31
52wk High:27.64
52wk Low:18.80
Shares:40.49M
Float Shares:36.90M
Volume Ratio:0.54
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1578
EPS(LYR):0.1578
ROE:0.96%
ROA:1.48%
PB:1.34
PE(LYR):144.96

Loading ...

May 07, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 21, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

Major Issues Report

Form 8-K - Current report
Oct 07, 2023

Correspondence

Form CORRESP - Correspondence
Sep 27, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities